| Selective Interim Reporting Financial Information |
The following table shows selected financial information for the twelve months ended December 31, 2024, twelve months ended December 31, 2023 and the comparative period ended December 31, 2022 (the “Comparative Period”). The Comparative Period information is derived from the Company’s unaudited, consolidated and combined financial statements.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Twelve Months Ended December 31, |
|
2024 |
|
2023 |
|
2022 |
|
|
|
|
|
(Unaudited) |
| Condensed income statement |
|
|
|
|
|
| Total revenues |
$ |
1,415,491 |
|
|
$ |
1,297,429 |
|
|
$ |
1,209,968 |
|
| Total costs and expenses |
1,285,955 |
|
|
1,244,955 |
|
|
1,179,397 |
|
| Loss on impairment |
— |
|
|
— |
|
|
(5,187) |
|
| Gains (losses) on disposal of assets |
(1,045) |
|
|
1,112 |
|
|
(521) |
|
| Earnings from unconsolidated affiliates |
4,117 |
|
|
7,165 |
|
|
1,136 |
|
| Operating income |
132,608 |
|
|
60,751 |
|
|
25,999 |
|
| Total other income (expense), net |
(30,545) |
|
|
(42,739) |
|
|
(6,036) |
|
| Income tax expense |
(7,193) |
|
|
(24,932) |
|
|
(10,754) |
|
| Net loss attributable to noncontrolling interests |
(73) |
|
|
140 |
|
|
6 |
|
| Net income (loss) attributable to Bristow Group Inc. |
$ |
94,797 |
|
|
$ |
(6,780) |
|
|
$ |
9,215 |
|
| Earnings (losses) per common share: |
|
|
|
|
|
| Basic |
$ |
3.32 |
|
|
$ |
(0.24) |
|
|
$ |
0.33 |
|
| Diluted |
$ |
3.21 |
|
|
$ |
(0.24) |
|
|
$ |
0.32 |
|
| Weighted average shares of common stock outstanding: |
|
|
|
|
|
| Basic |
28,515 |
|
|
28,139 |
|
|
28,104 |
|
| Diluted |
29,552 |
|
|
28,139 |
|
|
28,406 |
|
|
|
|
|
|
|
| Condensed cash flows |
|
|
|
|
|
| Net cash provided by (used in) operating activities |
$ |
177,420 |
|
|
$ |
32,037 |
|
|
$ |
(7,727) |
|
| Net cash used in investing activities |
(245,954) |
|
|
(47,319) |
|
|
(51,984) |
|
| Net cash provided by (used in) financing activities |
141,104 |
|
|
22,035 |
|
|
(24,623) |
|
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
(4,951) |
|
|
13,226 |
|
|
(29,445) |
|
| Net increase (decrease) in cash, cash equivalents and restricted cash |
67,619 |
|
|
19,979 |
|
|
(113,779) |
|
| Cash, cash equivalents and restricted cash at beginning of period |
183,662 |
|
|
163,683 |
|
|
277,462 |
|
| Cash, cash equivalents and restricted cash at end of period |
$ |
251,281 |
|
|
$ |
183,662 |
|
|
$ |
163,683 |
|
|
|
|
|
|
|
| Condensed balance sheets |
|
|
|
|
|
| Total assets |
$ |
2,125,246 |
|
|
$ |
1,937,278 |
|
|
$ |
1,812,001 |
|
| Total liabilities |
$ |
1,233,974 |
|
|
$ |
1,114,099 |
|
|
$ |
1,025,062 |
|
| Total stockholders’ equity |
$ |
891,272 |
|
|
$ |
823,179 |
|
|
$ |
786,939 |
|
|